Patients with active asthma at higher risk for heart attack
Patients with active asthma — such as any use of asthma medications, and unscheduled office or emergency visits for asthma — are at a twofold risk of having… read more.
Patients with active asthma — such as any use of asthma medications, and unscheduled office or emergency visits for asthma — are at a twofold risk of having… read more.
Only 16 percent of epinephrine users and 7 percent of inhaler users got it right. Millions of Americans with severe allergies and asthma are prescribed medical devices to… read more.
Asthma symptoms affect millions of patients and are one of the leading causes of work and school absences. People who suffer from asthma know it’s a challenge to… read more.
Monoclonal antibodies directed against tumour antigens have proven effective for treating some forms of cancer. Despite the increasing use of monoclonal antibody therapy, it is not clear how… read more.
In a new paper in the journal Infection and Immunity, the researchers lay out for the first time exactly how C. difficile wreaks havoc on the guts of… read more.
Cystic fibrosis is a genetic disorder that affects one out of every 3,000 children in populations of Northern European descent. One of the key signs of cystic fibrosis… read more.
by Bruce Sylvester: Treatment with the growth hormone growth factor-1 (IGF-1) significantly improves social impairment associated with autism spectrum disorder (ASD) in patients with a related genetic syndrome,… read more.
by Bruce Sylvester: Results from a French pilot study suggest that gallopamil effectively reduces symptoms in severe asthma. The findings appeared on January 28, 2015 in the American… read more.
Public health researchers have analyzed soda consumption data in order to characterize people’s exposure to a potentially carcinogenic byproduct of some types of caramel color.
Lack of sleep can elevate levels of free fatty acids in the blood, accompanied by temporary pre-diabetic conditions in healthy young men, according to new research published.
by Bruce Sylvester: Ranibizumab (Lucentis®) therapy appears to have efficacy in reversing diabetes-related vision loss in some populations, researchers reported online on Feb. 19 in the journal Opthalmology.
New research introduces a new approach to stimulate the skin immune response by applying needle-free vaccination.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.